1016 related articles for article (PubMed ID: 11884483)
21. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages.
Maier C; Ramming A; Bergmann C; Weinkam R; Kittan N; Schett G; Distler JHW; Beyer C
Ann Rheum Dis; 2017 Jun; 76(6):1133-1141. PubMed ID: 28209630
[TBL] [Abstract][Full Text] [Related]
22. Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease.
Kavian N; Marut W; Servettaz A; Laude H; Nicco C; Chéreau C; Weill B; Batteux F
J Immunol; 2012 May; 188(10):5142-9. PubMed ID: 22491256
[TBL] [Abstract][Full Text] [Related]
23. A modified graft-versus-host-induced model for systemic sclerosis, with pulmonary fibrosis in Rag2-deficient mice.
Yang X; Liu C; Fujino M; Yang J; Li XK; Zou H
FEBS Open Bio; 2017 Sep; 7(9):1316-1327. PubMed ID: 28904861
[TBL] [Abstract][Full Text] [Related]
24. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.
Murai M; Yoneyama H; Harada A; Yi Z; Vestergaard C; Guo B; Suzuki K; Asakura H; Matsushima K
J Clin Invest; 1999 Jul; 104(1):49-57. PubMed ID: 10393698
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 gp120 stimulates the production of beta-chemokines in human peripheral blood monocytes through a CD4-independent mechanism.
Fantuzzi L; Canini I; Belardelli F; Gessani S
J Immunol; 2001 May; 166(9):5381-7. PubMed ID: 11313374
[TBL] [Abstract][Full Text] [Related]
26. T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease.
Serody JS; Burkett SE; Panoskaltsis-Mortari A; Ng-Cashin J; McMahon E; Matsushima GK; Lira SA; Cook DN; Blazar BR
Blood; 2000 Nov; 96(9):2973-80. PubMed ID: 11049973
[TBL] [Abstract][Full Text] [Related]
27. Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis.
Chujo S; Shirasaki F; Kondo-Miyazaki M; Ikawa Y; Takehara K
J Cell Physiol; 2009 Jul; 220(1):189-95. PubMed ID: 19277979
[TBL] [Abstract][Full Text] [Related]
28. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.
Hasegawa M; Sato S; Takehara K
Clin Exp Immunol; 1999 Jul; 117(1):159-65. PubMed ID: 10403930
[TBL] [Abstract][Full Text] [Related]
29. beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi.
Aliberti JC; Machado FS; Souto JT; Campanelli AP; Teixeira MM; Gazzinelli RT; Silva JS
Infect Immun; 1999 Sep; 67(9):4819-26. PubMed ID: 10456936
[TBL] [Abstract][Full Text] [Related]
30. CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression.
Takeshita S; Takeshita F; Haddad DE; Ishii KJ; Klinman DM
Cell Immunol; 2000 Dec; 206(2):101-6. PubMed ID: 11161441
[TBL] [Abstract][Full Text] [Related]
31. RANTES-induced chemokine cascade in dendritic cells.
Fischer FR; Luo Y; Luo M; Santambrogio L; Dorf ME
J Immunol; 2001 Aug; 167(3):1637-43. PubMed ID: 11466387
[TBL] [Abstract][Full Text] [Related]
32. Allograft inflammatory factor-1 is overexpressed and induces fibroblast chemotaxis in the skin of sclerodermatous GVHD in a murine model.
Yamamoto A; Ashihara E; Nakagawa Y; Obayashi H; Ohta M; Hara H; Adachi T; Seno T; Kadoya M; Hamaguchi M; Ishino H; Kohno M; Maekawa T; Kawahito Y
Immunol Lett; 2011 Mar; 135(1-2):144-50. PubMed ID: 21040744
[TBL] [Abstract][Full Text] [Related]
33. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
Tran EH; Prince EN; Owens T
J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of murine sclerodermatous models by the selective S1P
Kano M; Kobayashi T; Date M; Tennichi M; Hamaguchi Y; Strasser DS; Takehara K; Matsushita T
Sci Rep; 2019 Jan; 9(1):658. PubMed ID: 30679645
[TBL] [Abstract][Full Text] [Related]
35. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
[TBL] [Abstract][Full Text] [Related]
36. TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice.
Brown GR; Lee E; Thiele DL
J Immunol; 2002 Mar; 168(6):3065-71. PubMed ID: 11884480
[TBL] [Abstract][Full Text] [Related]
37. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
[TBL] [Abstract][Full Text] [Related]
38. Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease.
Schultz KR; Bader S; Paquet J; Li W
Blood; 1995 Dec; 86(11):4344-52. PubMed ID: 7492796
[TBL] [Abstract][Full Text] [Related]
39. Chemokine expression by intraepithelial gamma delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia.
Boismenu R; Feng L; Xia YY; Chang JC; Havran WL
J Immunol; 1996 Aug; 157(3):985-92. PubMed ID: 8757601
[TBL] [Abstract][Full Text] [Related]
40. Profibrotic Activation of Human Macrophages in Systemic Sclerosis.
Bhandari R; Ball MS; Martyanov V; Popovich D; Schaafsma E; Han S; ElTanbouly M; Orzechowski NM; Carns M; Arroyo E; Aren K; Hinchcliff M; Whitfield ML; Pioli PA
Arthritis Rheumatol; 2020 Jul; 72(7):1160-1169. PubMed ID: 32134204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
